Cargando…
Hemophagocytic Lymphohistiocytosis Associated with Immunological Checkpoint Inhibitors: A Pharmacovigilance Study
Background: Acquired hemophagocytic lymphohistiocytosis (HLH) is a rare but potentially fatal condition characterized by hyperactivation of macrophages and cytotoxic lymphocytes, combining a series of non-specific clinical symptoms and laboratory disorders. Etiologies are multiple: infectious (mainl...
Autores principales: | Diaz, Laurine, Jauzelon, Benjamin, Dillies, Anne-Charlotte, Le Souder, Cosette, Faillie, Jean-Luc, Maria, Alexandre Thibault Jacques, Palassin, Pascale |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10004618/ https://www.ncbi.nlm.nih.gov/pubmed/36902771 http://dx.doi.org/10.3390/jcm12051985 |
Ejemplares similares
-
Hemophagocytic Lymphohistiocytosis Secondary to Immune Checkpoint Inhibitor Therapy
por: Rajapakse, Pramuditha, et al.
Publicado: (2022) -
Hemophagocytic Lymphohistiocytosis
por: Kaçar, Ayşe Gonca, et al.
Publicado: (2022) -
Comprehensive description of adult-onset Still's disease after COVID-19 vaccination
por: Palassin, Pascale, et al.
Publicado: (2023) -
Hemophagocytic lymphohistiocytosis in adults
por: Machaczka, Maciej
Publicado: (2013) -
Hemophagocytic lymphohistiocytosis in adults
por: Lee, Hyun Jeong, et al.
Publicado: (2014)